Literature DB >> 19533545

[Evidence-based and consented pathways for patients with inflammatory bowel diseases (IBD)].

H Raspe1, S Conrad, C Muche-Borowski.   

Abstract

Crohn's disease and ulcerative colitis are diseases characterized by remission and relapse, an early age of onset and restrictions on activities and participation. IBD patients need a comprehensive, easily accessible and problem-oriented health care. This requires the integration and coordination of different health care sectors, medical and non-medical professionals, social and health care facilities and funding agencies. The pathways to guide patients through integrated health care were based on clinical considerations, interviews with patients and specialists, systematically searched evidence and results of a questionnaire survey. Within a systematic assessment-assignment approach relevant problems were identified and subsequently related to different medical and non-medical professionals, health care services and medical sectors. The pathways further imply (1) medical care according to evidence-based guideline recommendations, (2) patient education programs to foster shared decision making and self-management and (3) suggestions for further research. The pathways were consented in a consensus conference using nominal group process methods. Their feasibility and effect will be evaluated within a regional implementation project.

Entities:  

Mesh:

Year:  2009        PMID: 19533545     DOI: 10.1055/s-0028-1109323

Source DB:  PubMed          Journal:  Z Gastroenterol        ISSN: 0044-2771            Impact factor:   2.000


  6 in total

1.  [Rehabilitation for digestive and metabolic diseases. Quo vadis?].

Authors:  R Stockbrugger; D Rosemeyer; U Armbrecht
Journal:  Internist (Berl)       Date:  2010-10       Impact factor: 0.743

2.  Healthcare Providers Underestimate Patients' Glucocorticoid Use in Crohn's Disease.

Authors:  Subrata Ghosh; Brian Bressler; Jill Petkau; Roopal B Thakkar; Song Wang; Martha Skup; Jingdong Chao; Remo Panaccione; Stefan Schreiber
Journal:  Dig Dis Sci       Date:  2019-01-19       Impact factor: 3.199

Review 3.  Optimising the Inflammatory Bowel Disease Unit to Improve Quality of Care: Expert Recommendations.

Authors:  Edouard Louis; Iris Dotan; Subrata Ghosh; Liat Mlynarsky; Catherine Reenaers; Stefan Schreiber
Journal:  J Crohns Colitis       Date:  2015-05-18       Impact factor: 9.071

4.  Co-designing inflammatory bowel disease (Ibd) services in Scotland: findings from a nationwide survey.

Authors:  Mariyana Schoultz; Leah Macaden; Angus J M Watson
Journal:  BMC Health Serv Res       Date:  2016-07-08       Impact factor: 2.655

5.  Regional differences in health care of patients with inflammatory bowel disease in Germany.

Authors:  Ansgar Lange; Anne Prenzler; Oliver Bachmann; Roland Linder; Sarah Neubauer; Jan Zeidler; Michael P Manns; J-Matthias von der Schulenburg
Journal:  Health Econ Rev       Date:  2015-10-16

6.  Quality of care in inflammatory bowel disease: results of a prospective controlled cohort study in Germany (NETIBD).

Authors:  Jana Langbrandtner; Angelika Hüppe; Petra Jessen; Jürgen Büning; Susanna Nikolaus; Heiner Raspe; Bernd Bokemeyer
Journal:  Clin Exp Gastroenterol       Date:  2017-09-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.